Success Stories: NIW Approved for Computational Modeling Expert Driving Innovation in Drug Delivery and Engineering Design
Client’s Testimonial:
“Excellent service. I’ve been speaking highly of your services with my friends/colleagues. Thank you very much!! I will be back again for EB-1!!”
On July 25th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Data/Modeling Scientist in the field of Computational Modeling (Approval Notice).
General Field: Computational Modeling
Position at the Time of Case Filing: Senior Data/Modeling Scientist
Country of Origin: India
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: July 25th, 2025
Processing Time: 1 month (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an EB-2 NIW approval. This approval was granted for a computational modeling expert specializing in open-source CFD-based simulation tools. The client’s research advances computational accessibility across multiple sectors, including drug delivery, filtration systems, and industrial design. As a senior data/modeling scientist, he applies simulation and modeling to solve real-world problems in engineering and healthcare.
Research with Substantial Merit and National Importance
The client’s work focuses on creating CFD-based simulation tools with advanced numerical algorithms to make complex modeling accessible and impactful across various sectors. His research is already influencing pulmonary drug delivery, fluid separation, and engineering design, with significant implications for U.S. manufacturing and public health. By improving inhalation therapies, optimizing industrial filtration, and supporting biomedical engineering, his tools contribute to national competitiveness and technological progress, especially as the global CFD market expands.
Well-Positioned to Advance the Proposed Endeavor
With a Ph.D. in mechanical engineering, the client has published 5 peer-reviewed journal articles (3 first-authored) and 1 conference abstract, earning 50 citations. His research has been recognized globally, particularly in drug delivery, lung modeling, and aerosol simulation, and has secured funding from the U.S. FDA, underscoring the national relevance of his work.
Recognized Contributions to Engineering and Healthcare
The client’s work on helical airflow modeling has significantly advanced drug deposition in the lungs, influencing inhaler design and respiratory treatment protocols. His nano-drug delivery simulation tools have enhanced therapeutic efficacy and minimized drug waste. Additionally, his CFD models have been widely adopted in aerosol behavior, drug delivery, and lung acoustics, advancing respiratory drug technologies.
Endorsements from Experts in the Field
The client’s work has been highly praised by leading experts in the field.
As one letter of recommendation expressed:
“[Client]’s research is progressing scientific understanding of complex fluid transport modeling and phenomena, facilitating innovation in medical and filtration technology design, and improving industrial.”
Such endorsements emphasize the significance of the client’s research and reinforce his role as a key innovator in the field.
NIW Approval and Outlook
With strong evidence of substantial merit, national importance, and the client’s exceptional qualifications, this NIW petition was approved just one month after filing, following an upgrade to premium processing. At NAILG, we are proud to support researchers who bridge engineering, public health, and technological innovation. The client’s contributions are shaping a future where accessible simulations lead to smarter treatments, safer devices, and faster industrial development.